FDA Approved: KEVEYIS — Supplemental Application (Xeris Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for KEVEYIS (dichlorphenamide) submitted by Xeris Pharmaceuticals, expanding the drug's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Hypokalemic Periodic Paralysis

Drugs mentioned

• KEVEYIS (DICHLORPHENAMIDE)

Snippet

SUPPL AP for KEVEYIS (DICHLORPHENAMIDE)